Afuresertib hydrochloride
|
A646676-100mg
|
≥99% |
1047645-82-8 |
100mg
|
¥ 7900.9
|
期货,请咨询 |
阿拉丁 |
Ac-Lys-AMC
|
A646659-5mg
|
≥98% |
156661-42-6 |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
(Aminooxy)acetamide-Val-Cit-PAB-MMAE
|
A646645-5mg
|
≥97% |
2446645-88-9 |
5mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
(Aminooxy)acetamide-Val-Cit-PAB-MMAE
|
A646645-1mg
|
≥97% |
2446645-88-9 |
1mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
AZ-23
|
A646643-5mg
|
≥98% |
915720-21-7 |
5mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
AZ-23
|
A646643-50mg
|
≥98% |
915720-21-7 |
50mg
|
¥ 11600.9
|
期货,请咨询 |
阿拉丁 |
AZ-23
|
A646643-2mg
|
≥98% |
915720-21-7 |
2mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
AZ-23
|
A646643-25mg
|
≥98% |
915720-21-7 |
25mg
|
¥ 7600.9
|
期货,请咨询 |
阿拉丁 |
AZ-23
|
A646643-10mg
|
≥98% |
915720-21-7 |
10mg
|
¥ 3600.9
|
期货,请咨询 |
阿拉丁 |
AZ-23
|
A646643-100mg
|
≥98% |
915720-21-7 |
100mg
|
¥ 19500.9
|
期货,请咨询 |
阿拉丁 |
ACT-1004-1239
|
A646636-5mg
|
≥99% |
2178049-58-4 |
5mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
ACT-1004-1239
|
A646636-10mg
|
≥99% |
2178049-58-4 |
10mg
|
¥ 10500.9
|
期货,请咨询 |
阿拉丁 |
AGN 192836
|
A646627-5mg
|
≥99% |
171102-29-7 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
AGN 192836
|
A646627-25mg
|
≥99% |
171102-29-7 |
25mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
AGN 192836
|
A646627-10mg
|
≥99% |
171102-29-7 |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
ACT-660602
|
A646614-5mg
|
≥99% |
1646267-59-5 |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
ACT-660602
|
A646614-25mg
|
≥99% |
1646267-59-5 |
25mg
|
¥ 14800.9
|
期货,请咨询 |
阿拉丁 |
ACT-660602
|
A646614-10mg
|
≥99% |
1646267-59-5 |
10mg
|
¥ 7000.9
|
期货,请咨询 |
阿拉丁 |
AC1-IN-1
|
A646607-5mg
|
≥99% |
2762422-55-7 |
5mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
AC1-IN-1
|
A646607-25mg
|
≥99% |
2762422-55-7 |
25mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
AC1-IN-1
|
A646607-10mg
|
≥99% |
2762422-55-7 |
10mg
|
¥ 6700.9
|
期货,请咨询 |
阿拉丁 |
AzddMeC
|
A646587-5mg
|
≥98% |
87190-79-2 |
5mg
|
¥ 2100.9
|
期货,请咨询 |
阿拉丁 |
AzddMeC
|
A646587-50mg
|
≥98% |
87190-79-2 |
50mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
AzddMeC
|
A646587-25mg
|
≥98% |
87190-79-2 |
25mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |